| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.926 | 0.004 | 0.926 | Analgesic | 0.791 0.006 CID_195975 | ||
| 0.667 | 0.009 | 0.667 | 5 Hydroxytryptamine release stimulant | 0.496 0.028 CID_195975 | ||
| 0.645 | 0.002 | 0.645 | Opioid mu receptor agonist | 0.291 0.004 CID_195975 | ||
| 0.635 | 0.003 | 0.635 | Opioid agonist | 0.231 0.005 CID_195975 | ||
| 0.615 | 0.003 | 0.615 | Analgesic, opioid | 0.306 0.005 CID_195975 | ||
| 0.554 | 0.025 | 0.554 | Aldehyde oxidase inhibitor | |||
| 0.532 | 0.004 | 0.532 | Opioid antagonist | 0.203 0.013 CID_195975 | ||
| 0.516 | 0.004 | 0.516 | Opioid mu receptor antagonist | 0.189 0.01 CID_195975 | ||
| 0.511 | 0.056 | 0.511 | Caspase 9 stimulant | 0.488 0.065 CID_195975 | ||
| 0.446 | 0.015 | 0.446 | Sigma receptor agonist | |||
| 0.383 | 0.023 | 0.383 | Sodium/bile acid cotransporter inhibitor | 0.333 0.052 CID_195975 | ||
| 0.377 | 0.026 | 0.386 | Psychostimulant | 0.386 0.025 CID_195975 | CID_195975 | |
| 0.343 | 0.014 | 0.343 | Lipocortins synthesis antagonist | 0.287 0.024 CID_195975 | ||
| 0.347 | 0.026 | 0.347 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.314 | 0.005 | 0.314 | Opioid kappa receptor antagonist | 0.094 0.041 CID_195975 | ||
| 0.313 | 0.006 | 0.313 | NMDA receptor antagonist | |||
| 0.311 | 0.015 | 0.318 | Neurotrophic factor enhancer | 0.318 0.014 CID_195975 | CID_195975 | |
| 0.287 | 0.022 | 0.463 | Interferon gamma antagonist | 0.463 0.008 CID_195975 | CID_195975 | |
| 0.355 | 0.113 | 0.355 | Calcium channel L-type activator | |||
| 0.256 | 0.025 | 0.347 | NOS3 expression enhancer | 0.347 0.012 CID_195975 | CID_195975 | |
| 0.229 | 0.01 | 0.229 | Estrogen antagonist | 0.115 0.065 CID_195975 | ||
| 0.222 | 0.004 | 0.222 | Opioid kappa receptor agonist | 0.099 0.009 CID_195975 | ||
| 0.354 | 0.137 | 0.544 | Apoptosis agonist | 0.544 0.062 CID_195975 | CID_195975 | |
| 0.219 | 0.006 | 0.219 | Prolactin inhibitor | |||
| 0.218 | 0.008 | 0.218 | Adenylate cyclase stimulant | 0.158 0.05 CID_195975 | ||
| 0.224 | 0.015 | 0.224 | Arachidonic acid antagonist | 0.174 0.061 CID_195975 | ||
| 0.24 | 0.031 | 0.533 | Amylase inhibitor | 0.533 0.005 CID_195975 | CID_195975 | |
| 0.295 | 0.094 | 0.576 | Cholesterol antagonist | 0.576 0.022 CID_195975 | CID_195975 | |
| 0.248 | 0.051 | 0.248 | Anesthetic general | 0.232 0.058 CID_195975 | ||
| 0.289 | 0.093 | 0.445 | Apoptosis antagonist | 0.445 0.028 CID_195975 | CID_195975 | |
| 0.282 | 0.087 | 0.419 | Interleukin 2 agonist | 0.419 0.022 CID_195975 | CID_195975 | |
| 0.198 | 0.005 | 0.198 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.058 0.024 CID_195975 | ||
| 0.198 | 0.008 | 0.198 | Estrogen agonist | 0.096 0.018 CID_195975 | ||
| 0.24 | 0.054 | 0.417 | Nitric oxide antagonist | 0.417 0.024 CID_195975 | CID_195975 | |
| 0.252 | 0.066 | 0.252 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.192 | 0.01 | 0.192 | Estrogen receptor beta antagonist | |||
| 0.212 | 0.035 | 0.276 | Interleukin 6 antagonist | 0.276 0.019 CID_195975 | CID_195975 | |
| 0.246 | 0.072 | 0.649 | Angiogenesis stimulant | 0.649 0.005 CID_195975 | CID_195975 | |
| 0.283 | 0.109 | 0.283 | Calcium channel activator | |||
| 0.21 | 0.038 | 0.21 | Phospholipase C inhibitor | 0.178 0.063 CID_195975 | ||
| 0.207 | 0.041 | 0.441 | Diuretic | 0.441 0.011 CID_195975 | CID_195975 | |
| 0.193 | 0.028 | 0.193 | Glutamate receptor antagonist | |||
| 0.177 | 0.015 | 0.177 | Opioid delta receptor antagonist | |||
| 0.167 | 0.006 | 0.167 | Estrogen receptor beta agonist | 0.065 0.017 CID_195975 | ||
| 0.311 | 0.152 | 0.734 | Cyclophilin D inhibitor | 0.734 0.011 CID_195975 | CID_195975 | |
| 0.27 | 0.113 | 0.27 | Vasodilator, peripheral | 0.25 0.127 CID_195975 | ||
| 0.224 | 0.069 | 0.224 | RNA-directed DNA polymerase inhibitor | 0.19 0.116 CID_195975 | ||
| 0.166 | 0.011 | 0.166 | Anabolic | 0.108 0.053 CID_195975 | ||
| 0.159 | 0.006 | 0.159 | NMDA 2C receptor antagonist | |||
| 0.267 | 0.115 | 0.592 | Transcription factor NF kappa B inhibitor | 0.592 0.032 CID_195975 | CID_195975 | |
| 0.172 | 0.02 | 0.172 | GABA C receptor antagonist | |||
| 0.228 | 0.085 | 0.383 | DNA synthesis inhibitor | 0.383 0.024 CID_195975 | CID_195975 | |
| 0.194 | 0.053 | 0.194 | Antipruritic | |||
| 0.162 | 0.021 | 0.162 | Ca2+-transporting ATPase inhibitor | 0.157 0.028 CID_195975 | ||
| 0.153 | 0.013 | 0.153 | Aromatase inhibitor | |||
| 0.14 | 0.003 | 0.14 | Dopamine D5 agonist | |||
| 0.201 | 0.064 | 0.422 | Hepatoprotectant | 0.422 0.011 CID_195975 | CID_195975 | |
| 0.154 | 0.021 | 0.154 | Androgen antagonist | |||
| 0.18 | 0.05 | 0.28 | Lipid peroxidase inhibitor | 0.28 0.022 CID_195975 | CID_195975 | |
| 0.226 | 0.098 | 0.514 | Antioxidant | 0.514 0.018 CID_195975 | CID_195975 | |
| 0.231 | 0.104 | 0.52 | Immunostimulant | 0.52 0.027 CID_195975 | CID_195975 | |
| 0.133 | 0.008 | 0.133 | 5-Alpha-reductase inhibitor | 0.055 0.017 CID_195975 | ||
| 0.136 | 0.014 | 0.136 | Estrogen receptor alpha antagonist | |||
| 0.158 | 0.044 | 0.158 | Farnesoid X receptor antagonist | |||
| 0.134 | 0.02 | 0.134 | NMDA 2 receptor antagonist | |||
| 0.121 | 0.008 | 0.121 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.237 | 0.125 | 0.282 | Caspase 3 stimulant | 0.282 0.088 CID_195975 | CID_195975 | |
| 0.27 | 0.159 | 0.636 | Antibacterial | 0.636 0.015 CID_195975 | CID_195975 | |
| 0.122 | 0.012 | 0.122 | Glycine receptor agonist | 0.107 0.017 CID_195975 | ||
| 0.145 | 0.036 | 0.145 | GABA C receptor agonist | |||
| 0.116 | 0.008 | 0.116 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.137 | 0.029 | 0.137 | DOPA decarboxylase inhibitor | |||
| 0.113 | 0.014 | 0.113 | Estrogen-related receptor beta agonist | |||
| 0.185 | 0.087 | 0.185 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.209 | 0.112 | 0.344 | Interleukin agonist | 0.344 0.031 CID_195975 | CID_195975 | |
| 0.101 | 0.008 | 0.101 | Estrogen receptor alpha agonist | |||
| 0.22 | 0.129 | 0.248 | Hypoxia-inducible factor 1 alpha inhibitor | 0.248 0.103 CID_195975 | CID_195975 | |
| 0.093 | 0.002 | 0.093 | NMDA receptor phencyclidine site antagonist | |||
| 0.101 | 0.012 | 0.101 | Bombesin 3 receptor antagonist | |||
| 0.147 | 0.058 | 0.147 | Pregnane X receptor agonist | |||
| 0.109 | 0.024 | 0.129 | Na+ K+ transporting ATPase inhibitor | 0.129 0.012 CID_195975 | CID_195975 | |
| 0.138 | 0.053 | 0.138 | Adenylate cyclase inhibitor | |||
| 0.134 | 0.054 | 0.134 | Cholesterol synthesis inhibitor | 0.097 0.091 CID_195975 | ||
| 0.096 | 0.017 | 0.096 | MAP kinase kinase 7 inhibitor | |||
| 0.199 | 0.121 | 0.3 | Spasmolytic | 0.3 0.07 CID_195975 | CID_195975 | |
| 0.135 | 0.058 | 0.158 | DNA polymerase I inhibitor | 0.158 0.045 CID_195975 | CID_195975 | |
| 0.105 | 0.028 | 0.105 | Keratolytic | |||
| 0.11 | 0.034 | 0.11 | Ornithine decarboxylase inhibitor | 0.089 0.057 CID_195975 | ||
| 0.108 | 0.033 | 0.116 | Glutamate release inhibitor | 0.116 0.025 CID_195975 | CID_195975 | |
| 0.15 | 0.077 | 0.15 | Cholinergic | |||
| 0.151 | 0.08 | 0.231 | Melanin inhibitor | 0.231 0.032 CID_195975 | CID_195975 | |
| 0.082 | 0.014 | 0.082 | Heme oxygenase stimulant | 0.066 0.032 CID_195975 | ||
| 0.113 | 0.046 | 0.113 | Creatine kinase inhibitor | |||
| 0.093 | 0.027 | 0.093 | Dopamine D1 antagonist | |||
| 0.102 | 0.038 | 0.102 | Acetylcholine nicotinic antagonist | |||
| 0.155 | 0.091 | 0.155 | Neurotensin receptor agonist | |||
| 0.233 | 0.17 | 0.233 | GABA C receptor rho-3 antagonist | |||
| 0.19 | 0.129 | 0.19 | Superoxide dismutase inhibitor | |||
| 0.065 | 0.005 | 0.065 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.112 | 0.054 | 0.112 | Nav1.1 sodium channel blocker | |||
| 0.112 | 0.057 | 0.342 | Expectorant | 0.342 0.006 CID_195975 | CID_195975 | |
| 0.074 | 0.018 | 0.08 | Lipocortins synthesis agonist | 0.08 0.014 CID_195975 | CID_195975 | |
| 0.118 | 0.063 | 0.161 | Microtubule formation inhibitor | 0.161 0.032 CID_195975 | CID_195975 | |
| 0.071 | 0.017 | 0.071 | Lysine-specific demethylase 1A inhibitor | |||
| 0.116 | 0.063 | 0.116 | TRPA1 agonist | |||
| 0.092 | 0.04 | 0.143 | Glycine receptor antagonist | 0.143 0.009 CID_195975 | CID_195975 | |
| 0.077 | 0.025 | 0.077 | Androgen agonist | |||
| 0.091 | 0.039 | 0.091 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.071 | 0.02 | 0.071 | Prolactin release inhibitor | |||
| 0.113 | 0.062 | 0.113 | 5 Hydroxytryptamine 3A agonist | |||
| 0.073 | 0.023 | 0.073 | NMDA 2A receptor antagonist | |||
| 0.222 | 0.174 | 0.47 | Immunosuppressant | 0.47 0.041 CID_195975 | CID_195975 | |
| 0.071 | 0.023 | 0.071 | Sigma receptor antagonist | |||
| 0.086 | 0.039 | 0.086 | GABA aminotransferase inhibitor | 0.076 0.052 CID_195975 | ||
| 0.062 | 0.016 | 0.062 | NMDA receptor subunit 3A antagonist | |||
| 0.111 | 0.066 | 0.111 | Alpha 2b adrenoreceptor antagonist | |||
| 0.098 | 0.053 | 0.098 | ABCA1 expression enhancer | |||
| 0.099 | 0.056 | 0.099 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.097 | 0.056 | 0.097 | Bile acid receptor antagonist | |||
| 0.101 | 0.061 | 0.101 | GABA C receptor rho-1 antagonist | |||
| 0.138 | 0.099 | 0.138 | CF transmembrane conductance regulator agonist | |||
| 0.207 | 0.168 | 0.632 | Antithrombotic | 0.632 0.013 CID_195975 | CID_195975 | |
| 0.049 | 0.012 | 0.049 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.071 | 0.034 | 0.071 | Beta tubulin antagonist | |||
| 0.045 | 0.009 | 0.045 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.04 0.011 CID_195975 | ||
| 0.053 | 0.018 | 0.053 | Parathyroid hormone antagonist | |||
| 0.114 | 0.079 | 0.114 | Cholinergic antagonist | |||
| 0.048 | 0.014 | 0.048 | RNA-directed RNA polymerase stimulant | 0.035 0.018 CID_195975 | ||
| 0.055 | 0.021 | 0.055 | Adenylate cyclase 1 inhibitor | |||
| 0.055 | 0.022 | 0.055 | NMDA receptor subunit 3B antagonist | |||
| 0.062 | 0.03 | 0.062 | Sphingosine kinase 2 inhibitor | |||
| 0.162 | 0.131 | 0.436 | Free radical scavenger | 0.436 0.024 CID_195975 | CID_195975 | |
| 0.037 | 0.005 | 0.037 | Hedgehog signaling activator | |||
| 0.219 | 0.188 | 0.312 | Antiobesity | 0.312 0.108 CID_195975 | CID_195975 | |
| 0.044 | 0.016 | 0.044 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.13 | 0.102 | 0.141 | Protein-tyrosine phosphatase inhibitor | 0.141 0.089 CID_195975 | CID_195975 | |
| 0.038 | 0.01 | 0.075 | Protein 30S ribosomal subunit inhibitor | 0.075 0.004 CID_195975 | CID_195975 | |
| 0.108 | 0.082 | 0.108 | Acetylcholine antagonist | |||
| 0.032 | 0.008 | 0.035 | Dopamine D1 agonist | 0.035 0.007 CID_195975 | CID_195975 | |
| 0.035 | 0.012 | 0.035 | Liver X receptor alpha antagonist | |||
| 0.04 | 0.019 | 0.04 | Glucocorticoid antagonist | |||
| 0.067 | 0.046 | 0.067 | Glutamate (mGluR6) antagonist | |||
| 0.036 | 0.015 | 0.036 | Glutamate (mGluR3) agonist | |||
| 0.037 | 0.016 | 0.037 | Liver X receptor antagonist | |||
| 0.098 | 0.079 | 0.098 | Cystathionine beta-synthase inhibitor | |||
| 0.103 | 0.083 | 0.205 | Topoisomerase II inhibitor | 0.205 0.032 CID_195975 | CID_195975 | |
| 0.092 | 0.073 | 0.092 | Alpha 2c adrenoreceptor antagonist | |||
| 0.176 | 0.158 | 0.176 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.028 | 0.011 | 0.028 | Estrone sulfatase inhibitor | |||
| 0.034 | 0.019 | 0.034 | Estrogen-related receptor beta antagonist | |||
| 0.025 | 0.01 | 0.025 | 5-Alpha-reductase 2 inhibitor | |||
| 0.019 | 0.004 | 0.019 | Antibiotic Tetracycline-like | 0.015 0.011 CID_195975 | ||
| 0.094 | 0.08 | 0.16 | Toll-Like receptor 4 antagonist | 0.16 0.016 CID_195975 | CID_195975 | |
| 0.036 | 0.024 | 0.036 | Progesterone antagonist | |||
| 0.116 | 0.104 | 0.116 | Peroxidase inhibitor | |||
| 0.036 | 0.024 | 0.036 | Opioid delta receptor agonist | |||
| 0.039 | 0.027 | 0.039 | GABA uptake inhibitor | |||
| 0.041 | 0.031 | 0.041 | Secretase gamma inhibitor | |||
| 0.163 | 0.153 | 0.185 | DNA damaging | 0.185 0.129 CID_195975 | CID_195975 | |
| 0.072 | 0.063 | 0.194 | Antineoplastic antibiotic | 0.194 0.022 CID_195975 | CID_195975 | |
| 0.13 | 0.121 | 0.134 | Heat shock protein 70 antagonist | 0.134 0.102 CID_195975 | CID_195975 | |
| 0.071 | 0.063 | 0.071 | Somatostatin 1 agonist | |||
| 0.032 | 0.024 | 0.032 | Carboxypeptidase B inhibitor | |||
| 0.045 | 0.037 | 0.045 | Aldosterone antagonist | |||
| 0.056 | 0.048 | 0.056 | Sphingosine kinase inhibitor | |||
| 0.111 | 0.103 | 0.229 | Protein kinase stimulant | 0.229 0.032 CID_195975 | CID_195975 | |
| 0.021 | 0.015 | 0.025 | Corticosteroid-like | 0.025 0.011 CID_195975 | CID_195975 | |
| 0.122 | 0.115 | 0.122 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.062 | 0.056 | 0.062 | Potassium channel large-conductance Ca-activated activator | |||
| 0.06 | 0.055 | 0.06 | Neuronal nicotinic receptor antagonist | |||
| 0.033 | 0.028 | 0.065 | Arginase inhibitor | 0.065 0.009 CID_195975 | CID_195975 | |
| 0.033 | 0.03 | 0.074 | Antibiotic Aminoglycoside-like | 0.074 0.005 CID_195975 | CID_195975 | |
| 0.037 | 0.035 | 0.037 | Oxytocin agonist | |||
| 0.016 | 0.014 | 0.023 | Telomerase stimulant | 0.023 0.005 CID_195975 | CID_195975 | |
| 0.043 | 0.041 | 0.043 | Mineralocorticoid receptor antagonist | |||
| 0.111 | 0.109 | 0.111 | Nav1.6 sodium channel blocker | |||
| 0.162 | 0.16 | 0.566 | Hypoglycemic | 0.566 0.01 CID_195975 | CID_195975 | |
| 0.074 | 0.073 | 0.074 | Inducible nitric-oxide synthase inhibitor | |||
| 0.077 | 0.076 | 0.142 | Transcription factor NF kappa B stimulant | 0.142 0.018 CID_195975 | CID_195975 | |
| 0.034 | 0.033 | 0.034 | Oxytocin antagonist | |||
| 0.065 | 0.064 | 0.065 | Alpha 2a adrenoreceptor antagonist | |||
| 0.04 | 0.042 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.06 0.013 CID_195975 | CID_195975 | |
| 0.057 | 0.061 | 0.092 | Neuraminidase (influenza) inhibitor | 0.092 0.019 CID_195975 | CID_195975 | |
| 0.017 | 0.021 | 0.027 | Antibiotic Anthracycline-like | 0.027 0.004 CID_195975 | CID_195975 | |
| 0.239 | 0.244 | 0.302 | 5 Hydroxytryptamine release inhibitor | 0.302 0.162 CID_195975 | CID_195975 | |
| 0.254 | 0.262 | 0.694 | Antiinflammatory | 0.694 0.032 CID_195975 | CID_195975 | |
| 0.097 | 0.107 | 0.258 | Cyclooxygenase 3 inhibitor | 0.258 0.008 CID_195975 | CID_195975 | |
| 0.093 | 0.104 | 0.102 | Acetylcholine release stimulant | 0.102 0.084 CID_195975 | CID_195975 | |
| 0.048 | 0.06 | 0.087 | Neuraminidase inhibitor | 0.087 0.021 CID_195975 | CID_195975 | |
| 0.086 | 0.101 | 0.093 | Mucolytic | 0.093 0.088 CID_195975 | CID_195975 | |
| 0.043 | 0.061 | 0.091 | Alpha-mannosidase inhibitor | 0.091 0.008 CID_195975 | CID_195975 | |
| 0.023 | 0.041 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 CID_195975 | CID_195975 | |
| 0.125 | 0.161 | 0.294 | Non-steroidal antiinflammatory agent | 0.294 0.029 CID_195975 | CID_195975 | |
| 0.007 | 0.044 | 0.02 | Ileal bile acid transport inhibitor | 0.02 0.009 CID_195975 | CID_195975 | |
| 0.052 | 0.089 | 0.113 | Topoisomerase II alpha inhibitor | 0.113 0.032 CID_195975 | CID_195975 | |
| 0.062 | 0.106 | 0.179 | Monophenol monooxygenase inhibitor | 0.179 0.038 CID_195975 | CID_195975 | |
| 0.113 | 0.16 | 0.142 | CC chemokine 6 receptor antagonist | 0.142 0.036 CID_195975 | CID_195975 | |
| 0.027 | 0.077 | 0.079 | Mannosidase inhibitor | 0.079 0.009 CID_195975 | CID_195975 | |
| 0.016 | 0.067 | 0.025 | Vanilloid 2 agonist | 0.025 0.017 CID_195975 | CID_195975 | |
| 0.076 | 0.127 | 0.17 | Alkylator | 0.17 0.037 CID_195975 | CID_195975 | |
| 0.028 | 0.087 | 0.046 | Microtubule stabilization | 0.046 0.033 CID_195975 | CID_195975 | |
| 0.072 | 0.131 | 0.101 | Interleukin 12 antagonist | 0.101 0.052 CID_195975 | CID_195975 | |
| 0.037 | 0.096 | 0.096 | Phosphofructokinase-1 inhibitor | 0.096 0.033 CID_195975 | CID_195975 | |
| 0.079 | 0.14 | 0.148 | Alpha-N-acetylglucosaminidase inhibitor | 0.148 0.056 CID_195975 | CID_195975 | |
| 0.062 | 0.132 | 0.099 | Protein-tyrosine phosphatase 1B inhibitor | 0.099 0.079 CID_195975 | CID_195975 | |
| 0.113 | 0.186 | 0.269 | Hypolipemic | 0.269 0.06 CID_195975 | CID_195975 | |
| 0.077 | 0.151 | 0.113 | Photosensitizer | 0.113 0.067 CID_195975 | CID_195975 | |
| 0.127 | 0.201 | 0.228 | Cyclic AMP phosphodiesterase inhibitor | 0.228 0.075 CID_195975 | CID_195975 | |
| 0.058 | 0.145 | 0.082 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.082 0.078 CID_195975 | CID_195975 | |
| 0.163 | 0.259 | 0.283 | Histamine release inhibitor | 0.283 0.133 CID_195975 | CID_195975 | |
| 0.057 | 0.155 | 0.095 | NADH dehydrogenase inhibitor | 0.095 0.049 CID_195975 | CID_195975 | |
| 0.146 | 0.246 | 0.33 | Vasodilator, coronary | 0.33 0.066 CID_195975 | CID_195975 | |
| 0.048 | 0.148 | 0.163 | Topoisomerase I inhibitor | 0.163 0.037 CID_195975 | CID_195975 | |
| 0.055 | 0.16 | 0.121 | UDP-glucose 4-epimerase inhibitor | 0.121 0.042 CID_195975 | CID_195975 | |
| 0.135 | 0.243 | 0.348 | Peptidyltransferase inhibitor | 0.348 0.013 CID_195975 | CID_195975 | |
| 0.087 | 0.207 | 0.347 | Platelet adhesion inhibitor | 0.347 0.02 CID_195975 | CID_195975 | |
| 0.016 | 0.139 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 CID_195975 | CID_195975 | |
| 0.037 | 0.163 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.038 CID_195975 | CID_195975 | |
| 0.014 | 0.141 | 0.047 | Phosphorylase inhibitor | 0.047 0.032 CID_195975 | CID_195975 | |
| 0.077 | 0.206 | 0.218 | Cell wall synthesis inhibitor | 0.218 0.024 CID_195975 | CID_195975 | |
| 0.054 | 0.186 | 0.097 | Thioredoxin inhibitor | 0.097 0.052 CID_195975 | CID_195975 | |
| 0.081 | 0.213 | 0.184 | Hexokinase inhibitor | 0.184 0.046 CID_195975 | CID_195975 | |
| 0.02 | 0.154 | 0.088 | Protein 50S ribosomal subunit inhibitor | 0.088 0.016 CID_195975 | CID_195975 | |
| 0.131 | 0.274 | 0.404 | Immunomodulator | 0.404 0.043 CID_195975 | CID_195975 | |
| 0.007 | 0.152 | 0.035 | Sodium/glucose cotransporter 2 inhibitor | 0.035 0.01 CID_195975 | CID_195975 | |
| 0.096 | 0.242 | 0.352 | Tumour necrosis factor alpha release inhibitor | 0.352 0.037 CID_195975 | CID_195975 | |
| 0.051 | 0.211 | 0.167 | AMP-activated protein kinase stimulant | 0.167 0.019 CID_195975 | CID_195975 | |
| 0.094 | 0.26 | 0.252 | Vasodilator | 0.252 0.068 CID_195975 | CID_195975 | |
| 0.009 | 0.178 | 0.031 | Sodium/glucose cotransporter inhibitor | 0.031 0.01 CID_195975 | CID_195975 | |
| 0.024 | 0.209 | 0.067 | Glucose-6-phosphate translocase inhibitor | 0.067 0.018 CID_195975 | CID_195975 | |
| 0.045 | 0.24 | 0.116 | Beta glucuronidase inhibitor | 0.116 0.049 CID_195975 | CID_195975 | |
| 0.042 | 0.269 | 0.243 | Thrombolytic | 0.243 0.035 CID_195975 | CID_195975 | |
| 0.064 | 0.336 | 0.247 | Hemostatic | 0.247 0.022 CID_195975 | CID_195975 | |
| 0.02 | 0.296 | 0.072 | Heparanase inhibitor | 0.072 0.01 CID_195975 | CID_195975 | |
| 0.075 | 0.354 | 0.169 | ATPase inhibitor | 0.169 0.072 CID_195975 | CID_195975 | |
| 0.011 | 0.326 | 0.297 | Selectin antagonist | 0.297 0.005 CID_195975 | CID_195975 | |
| 0.02 | 0.346 | 0.063 | Factor IXa inhibitor | 0.063 0.024 CID_195975 | CID_195975 | |
| 0.045 | 0.374 | 0.079 | T cell inhibitor | 0.079 0.069 CID_195975 | CID_195975 | |
| 0.055 | 0.406 | 0.125 | DNA repair enzyme inhibitor | 0.125 0.063 CID_195975 | CID_195975 | |
| 0.046 | 0.435 | 0.18 | Insulin secretagoues | 0.18 0.048 CID_195975 | CID_195975 | |
| 0.021 | 0.421 | 0.1 | ATPase (Vacuolar H+) inhibitor | 0.1 0.04 CID_195975 | CID_195975 | |
| 0.033 | 0.462 | 0.208 | Platelet antagonist | 0.208 0.096 CID_195975 | CID_195975 | |
| 0.03 | 0.482 | 0.167 | Cell adhesion inhibitor | 0.167 0.037 CID_195975 | CID_195975 | |
| 0.009 | 0.722 | 0.131 | Anticoagulant | 0.131 0.099 CID_195975 | CID_195975 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |